SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-019391
Filing Date
2019-10-01
Accepted
2019-10-01 16:12:58
Documents
2
Period of Report
2019-09-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k093019_delmarpharma.htm 8-K 32236
2 LETTER FROM ERNST & YOUNG LLP TO THE U.S. SECURITIES AND EXCHANGE COMMISSION, DA f8k093019ex16-1_delmar.htm EX-16.1 2034
  Complete submission text file 0001213900-19-019391.txt   35484
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 191129231
SIC: 2834 Pharmaceutical Preparations